236 related articles for article (PubMed ID: 32987103)
1. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
Oany AR; Pervin T; Moni MA
Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
[TBL] [Abstract][Full Text] [Related]
4. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
Dhameliya TM; Nagar PR; Gajjar ND
Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing.
Aloufi BH; Snoussi M; Sulieman AME
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458599
[TBL] [Abstract][Full Text] [Related]
6. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
Shah M; Yamin R; Ahmad I; Wu G; Jahangir Z; Shamim A; Nawaz H; Nishan U; Ullah R; Ali EA; Sheheryar ; Chen K
PLoS One; 2024; 19(1):e0294769. PubMed ID: 38175855
[TBL] [Abstract][Full Text] [Related]
7. Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies.
Azad I; Khan T; Maurya AK; Irfan Azad M; Mishra N; Alanazi AM
J Mol Recognit; 2021 Oct; 34(10):e2918. PubMed ID: 34132436
[TBL] [Abstract][Full Text] [Related]
8. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
Chandel V; Sharma PP; Raj S; Choudhari R; Rathi B; Kumar D
J Biomol Struct Dyn; 2022 Jan; 40(1):249-262. PubMed ID: 32838660
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies.
Majeed A; Hussain W; Yasmin F; Akhtar A; Rasool N
Biomed Res Int; 2021; 2021():6661191. PubMed ID: 34095308
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
Fantini J; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.
Bouback TA; Pokhrel S; Albeshri A; Aljohani AM; Samad A; Alam R; Hossen MS; Al-Ghamdi K; Talukder MEK; Ahammad F; Qadri I; Simal-Gandara J
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443556
[TBL] [Abstract][Full Text] [Related]
12. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein.
Power H; Wu J; Turville S; Aggarwal A; Valtchev P; Schindeler A; Dehghani F
Bioorg Chem; 2022 Feb; 119():105574. PubMed ID: 34971947
[TBL] [Abstract][Full Text] [Related]
15. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
Romeo A; Iacovelli F; Falconi M
Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
[TBL] [Abstract][Full Text] [Related]
16. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
[TBL] [Abstract][Full Text] [Related]
17. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.
Bharadwaj S; Dubey A; Yadava U; Mishra SK; Kang SG; Dwivedi VD
Brief Bioinform; 2021 Mar; 22(2):1361-1377. PubMed ID: 33406222
[TBL] [Abstract][Full Text] [Related]
18. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
[TBL] [Abstract][Full Text] [Related]
20. Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.
Shanmugam A; Venkattappan A; Gromiha MM
Curr Top Med Chem; 2022; 22(29):2396-2409. PubMed ID: 36330617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]